18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels

European Journal of Nuclear Medicine

Volumn 28, Issue 1, 2001, Pages 64-71

  Hoegerle, Stefan ^a   Altehoefer, Carsten ^a   Ghanem, Nadir ^a   Brink, Ingo ^a   Moser, Ernst ^a   Nitzsche, Egbert ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

111In pentetreotide; 18F DOPA PET; 18F FDG PET; Calcitonin; Medullary thyroid carcinoma; Somatostatin receptor scintigraphy

Indexed keywords

CALCITONIN; DIAGNOSTIC AGENT; DOPA; DRUG DERIVATIVE; FLUORODEOXYGLUCOSE F 18; FLUORODOPA F 18; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN RECEPTOR; FLUORINE 18;

AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; MALE; MEDULLARY CARCINOMA; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; SCINTISCANNING; THYROID TUMOR; ADULT; CALCITONIN BLOOD LEVEL; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; LYMPH NODE METASTASIS; POSITRON EMISSION TOMOGRAPHY; THYROID MEDULLARY CARCINOMA;

AGED; CALCITONIN; CARCINOMA, MEDULLARY; DIHYDROXYPHENYLALANINE; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; RECEPTORS, SOMATOSTATIN; THYROID NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0034746433     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590000404     Document Type: Article

References (35)

1. Medullary carcinoma of the thyroid: A study of the clinical features and prognostic factors in 161 patients
2. Medullary carcinoma of the thyroid: Current diagnosis and management
3. Calcitonin as a tumor marker. Use of the radioimmunoassay for calcitonin in the postoperative evaluation of patients with medullary thyroid carcinoma
4. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid cancer
5. Nonparallel patterns of calcitonin and carcinoembryonic antigen levels in the follow-up of medullary thyroid carcinoma
6. Changing concepts in the management of hereditary and sporadic medullary carcinoma
7. Interobserver variability and accuracy of computed tomographic assessment of nodal status in lung cancer
8. Comparison of imaging TNM [(i)TNM] and pathological TNM [pTNM] in staging of bronchogenic carcinoma
9. Pancreatic neuroendocrine tumors: Diagnosis with PET
10. In vivo demonstration of enzyme activity in endocrine pancreatic tumors: Decarboxylation of carbon-DOPA to carbondopamine
11. Imaging of a metastatic gastrointestinal carcinoid by F-18-DOPA positron emission tomography
12. Remote, semiautomated production of 6-[F-18]fluoro-L-dopa for human studies with PET
13. Simple rapid hydrolysis of acetyl protecting groups in FDG synthesis using cation exchange resins
14. Accelerated image reconstruction using ordered subsets of projection data
15. Nigrostriatal function in humans studied with positron emission tomography
16. Kinetics and modeling of L-6-[18F]fluoro-DOPA in human positron emission tomographic studies
17. The cytochemistry and ultrastructure of polypeptide hormone producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the concept
18. 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoid of the thyroid
19. Technetium-99m-sestamibi scanning in recurrent medullary carcinoma
20. Indium-111-DTPA-D-Phe-1-octreotide and technetium-99m-(V)-dimercaptosuccinic acid scanning in the preoperative staging of medullary thyroid carcinoma
21. 99mTc tetrofosmin
22. Use of somatostatin analogue scintigraphy in the localization of recurrent medullary thyroid carcinoma
23. Somatostatin receptor scintigraphy for early detection of regional and distant metastases of medullary carcinoma of the thyroid
24. 111In-labeled F(ab')2 fragments of carcinoembryonic antigen monoclonal antibody for detecting recurrences of medullary thyroid carcinoma
25. Improved detection of medullary thyroid cancer with radiolabeled antibodies to carcinoembryonic antigen
26. Metaiodobenzylguanidine and somatostatin in oncology: Role in the management of neural crest tumours
27. Somatostatin receptors and somatostatin content in medullary thyroid carcinomas
28. PET imaging of medullary thyroid cancer
29. Limited value of fluorine-18 fluordeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours
30. FDG-PET for predicting the prognosis of malignant lymphoma
31. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer
32. Positron emission tomography with 5-hydroxytryptophan in neuroendocrine tumors
33. Targeting of cholecystokinin-B/gastrin receptors in vivo: Preclinical and initial clinical evaluation of the diagnostic and therapeutic potential of radiolabelled gastrin
34. Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors